Community Pharmacies and BioPharma: Advancing Whole-Patient Care Together
The healthcare landscape has become increasingly complex, with a growing population and more people developing complex and chronic conditions.
Advanced therapies, such as cell and gene therapies, are being approved at an accelerated rate, with
25% of all FDA-approved cell and gene therapiesbeing approved within the last 18 months.
- Biologics, including glucagon-like peptide-1 receptor agonists (GLP-1s) for weight loss, are gaining market share.
- The number of prescriptions for specialty medications has risen dramatically over the past five years.
Community pharmacies can help simplify and coordinate patient care amidst this complexity.
Author's summary: Community pharmacies and BioPharma collaborate for better patient care.
More News
- MMJ BioPharma Cultivation: EXPOSÉ: DEA's Marijuana Licensing Scheme Exposed - MMJ BioPharma's Case Reveals DEA Contradiction Blocking FDA Approved Cannabis Medicine
- Canada’s Lululemon Partners With National Football League
- Why Experienced Lawyers Matter in a Personal Injury Case | NorthPennNow
- BioDlink Biopharm Co., Ltd.: BioDlink Completes First International Shipment of Bevacizumab to Colombia
- Staffordshire Leader Reacts to "Squandered" Billions of Taxpayers' Money on Asylum Hotels - Staffordshire County Council Newsroom
- The environmental impact of the 2026 World Cup
- Deandre Ayton claims Los Angeles Lakers superstars ‘troll him’ to get him going
- Elon Musk could step down if Tesla pay plan is rejected
- Liam Hemsworth vs. Gabriella Brooks: Who Has the Higher Net Worth?
- Landmark New Report Shows Canadian Lobbyists Represent Major Polluters Alongside Environmental Groups